CHWY vs EBS · P/E 45, rev $11.86B vs rev $1.04B
Chewy Inc (CHWY) versus Emergent Biosolutions Inc (EBS) — a side-by-side from cached financials, not a winner call.
Chewy Inc (CHWY) is a internet retail company listed on US.
Emergent Biosolutions Inc (EBS) is a drug manufacturers - specialty & generic company listed on US.
Latest reported CHWY revenue for 2025-02-02 was $11.86B. Net income was $392.7M. Revenue was up 6.4% from 2024-01-28 to 2025-02-02. CHWY currently screens at market cap $16.92B and trailing P/E 45.0.
Latest reported EBS revenue for 2024-12-31 was $1.04B. Net income was -$190.6M. Revenue was down 0.5% from 2023-12-31 to 2024-12-31. EBS currently screens at market cap $416.4M.
CHWY currently screens at market cap $16.92B and trailing P/E 45.0. EBS currently screens at market cap $416.4M.
Not investment advice. Open the CHWY and EBS stock pages for the full models.
Not investment advice.